Cancer,geneA,geneB,p-Value,Log Odds Ratio,Association
Pan-Lung,MYC,TP53,0.14204384500000,0.267194001,Tendency towards co-occurrence
Pan-Lung,MYC,GSTA1,0.07975852100000,0.798507696,Tendency towards co-occurrence
Pan-Lung,MYC,GSTM2,0.01617119000000,1.432006341,Tendency towards co-occurrence(Significant)
Pan-Lung,MYC,GSTP1,0.39279971000000,0.33332758,Tendency towards co-occurrence
Pan-Lung,MYC,PIK3CA,0.29554338500000,-0.164303051,Tendency towards mutual exclusivity
Pan-Lung,MYC,RALBP1,0.25926882400000,0.610170485,Tendency towards co-occurrence
Pan-Lung,TP53,GSTA1,0.00174642100000,1.587756846,Tendency towards co-occurrence(Significant)
Pan-Lung,TP53,GSTM2,0.31529652200000,0.438550833,Tendency towards co-occurrence
Pan-Lung,TP53,GSTP1,0.30191193900000,0.359573115,Tendency towards co-occurrence
Pan-Lung,TP53,PIK3CA,0.00000000000011,1.242554339,Tendency towards co-occurrence(Significant)
Pan-Lung,TP53,RALBP1,0.09331606400000,0.940555354,Tendency towards co-occurrence
Pan-Lung,GSTA1,GSTM2,0.08379191100000,1.550532242,Tendency towards co-occurrence
Pan-Lung,GSTA1,GSTP1,0.49176395000000,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTA1,PIK3CA,0.14756218700000,0.467642353,Tendency towards co-occurrence
Pan-Lung,GSTA1,RALBP1,0.42914858000000,0.640573827,Tendency towards co-occurrence
Pan-Lung,GSTM2,GSTP1,0.69557946800000,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTM2,PIK3CA,0.08988468600000,0.803217776,Tendency towards co-occurrence
Pan-Lung,GSTM2,RALBP1,0.75070611600000,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,GSTP1,PIK3CA,0.35313156900000,0.264397554,Tendency towards co-occurrence
Pan-Lung,GSTP1,RALBP1,0.66625664700000,#NAME?,Tendency towards mutual exclusivity
Pan-Lung,PIK3CA,RALBP1,0.29858406300000,0.379489622,Tendency towards co-occurrence
Bladder Uroethelial,MYC,TP53,0.46925285300000,-0.16034265,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTA1,0.58951744500000,-0.384845821,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTM2,0.14991931700000,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,GSTP1,0.59328816100000,-0.172416028,Tendency towards mutual exclusivity
Bladder Uroethelial,MYC,PIK3CA,0.17430773100000,0.611082228,Tendency towards co-occurrence
Bladder Uroethelial,MYC,RALBP1,0.31915608600000,0.481053465,Tendency towards co-occurrence
Bladder Uroethelial,TP53,GSTA1,0.37960497100000,0.485507816,Tendency towards co-occurrence
Bladder Uroethelial,TP53,GSTM2,0.14573516600000,-0.878069519,Tendency towards mutual exclusivity
Bladder Uroethelial,TP53,GSTP1,0.27347278500000,0.510825624,Tendency towards co-occurrence
Bladder Uroethelial,TP53,PIK3CA,0.00679347100000,1.098612289,Tendency towards co-occurrence(Significant)
Bladder Uroethelial,TP53,RALBP1,0.17571568000000,0.621958919,Tendency towards co-occurrence
Bladder Uroethelial,GSTA1,GSTM2,0.42391500600000,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTA1,GSTP1,0.70560671200000,-0.093526058,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTA1,PIK3CA,0.55257344200000,0.145953913,Tendency towards co-occurrence
Bladder Uroethelial,GSTA1,RALBP1,0.21476843700000,#NAME?,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,GSTP1,0.60929266200000,-0.336472237,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,PIK3CA,0.29154751000000,-0.730887509,Tendency towards mutual exclusivity
Bladder Uroethelial,GSTM2,RALBP1,0.06326383400000,1.327453861,Tendency towards co-occurrence
Bladder Uroethelial,GSTP1,PIK3CA,0.04286162100000,1.114360646,Tendency towards co-occurrence(Significant)
Bladder Uroethelial,GSTP1,RALBP1,0.59328816100000,-0.172416028,Tendency towards mutual exclusivity
Bladder Uroethelial,PIK3CA,RALBP1,0.17430773100000,0.611082228,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,TP53,0.11722838700000,0.988376459,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,GSTA1,0.68217014000000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,GSTM2,0.61900623800000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,GSTP1,0.18936919800000,1.152100974,Tendency towards co-occurrence
Acute Myeloid Leukemia,MYC,PIK3CA,0.46071822500000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,MYC,RALBP1,0.62285961900000,0.119545151,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,GSTA1,0.08546807300000,1.960094784,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,GSTM2,0.48662624000000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,TP53,GSTP1,0.00231905200000,2.33157263,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,TP53,PIK3CA,0.28666954800000,0.832909123,Tendency towards co-occurrence
Acute Myeloid Leukemia,TP53,RALBP1,0.02877068500000,1.631416819,Tendency towards co-occurrence(Significant)
Acute Myeloid Leukemia,GSTA1,GSTM2,0.88384596800000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,GSTP1,0.79846003800000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,PIK3CA,0.81919926000000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTA1,RALBP1,0.77811710700000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,GSTP1,0.75410114700000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,PIK3CA,0.77874497500000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTM2,RALBP1,0.73008518700000,#NAME?,Tendency towards mutual exclusivity
Acute Myeloid Leukemia,GSTP1,PIK3CA,0.36613260600000,0.985283603,Tendency towards co-occurrence
Acute Myeloid Leukemia,GSTP1,RALBP1,0.43650553200000,0.720546155,Tendency towards co-occurrence
Acute Myeloid Leukemia,PIK3CA,RALBP1,0.39843158100000,0.86081158,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,TP53,0.00268888700000,1.262793634,Tendency towards co-occurrence(Significant)
Colorectal Adenocarcinoma,MYC,GSTA1,0.46898783800000,0.356674944,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,GSTM2,0.23974279600000,-1.107580959,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,MYC,GSTP1,0.52914971900000,0.216671037,Tendency towards co-occurrence
Colorectal Adenocarcinoma,MYC,PIK3CA,0.37019293900000,-0.286681572,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,MYC,RALBP1,0.18448014200000,-0.890240055,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTA1,0.35461214100000,-0.482654747,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTM2,0.31418223500000,-0.401795379,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,GSTP1,0.02112333900000,-1.702414369,Tendency towards mutual exclusivity(Significant)
Colorectal Adenocarcinoma,TP53,PIK3CA,0.18866968100000,-0.364973747,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,TP53,RALBP1,0.31921630600000,0.311336263,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,GSTM2,0.52109407300000,0.428995606,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,GSTP1,0.61626329500000,#NAME?,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,GSTA1,PIK3CA,0.31544421200000,0.601579987,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTA1,RALBP1,0.30579222700000,0.756061006,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTM2,GSTP1,0.17350106100000,1.196250758,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTM2,PIK3CA,0.31548713800000,-0.65090031,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,GSTM2,RALBP1,0.27519560800000,0.638087403,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTP1,PIK3CA,0.38452829800000,0.440556428,Tendency towards co-occurrence
Colorectal Adenocarcinoma,GSTP1,RALBP1,0.64528411700000,-0.245122458,Tendency towards mutual exclusivity
Colorectal Adenocarcinoma,PIK3CA,RALBP1,0.55811022000000,-0.082238098,Tendency towards mutual exclusivity
Breast Cancer (Cell),MYC,TP53,0.00000000000001,1.351337968,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),MYC,GSTA1,0.05217242600000,0.883190783,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,GSTM2,0.26437299000000,0.387510483,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,GSTP1,0.44258829800000,0.085309249,Tendency towards co-occurrence
Breast Cancer (Cell),MYC,PIK3CA,0.08617579100000,-0.255090119,Tendency towards mutual exclusivity
Breast Cancer (Cell),MYC,RALBP1,0.05799092600000,0.481144172,Tendency towards co-occurrence
Breast Cancer (Cell),TP53,GSTA1,0.00045431300000,1.693441236,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),TP53,GSTM2,0.02256977100000,0.917979446,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),TP53,GSTP1,0.48215790100000,0.045657002,Tendency towards co-occurrence
Breast Cancer (Cell),TP53,PIK3CA,0.01823264400000,-0.325928935,Tendency towards mutual exclusivity(Significant)
Breast Cancer (Cell),TP53,RALBP1,0.00001510000000,1.093099436,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),GSTA1,GSTM2,0.54649433100000,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTA1,GSTP1,0.19133825100000,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTA1,PIK3CA,0.55215217200000,0.038890871,Tendency towards co-occurrence
Breast Cancer (Cell),GSTA1,RALBP1,0.23521869600000,0.668788737,Tendency towards co-occurrence
Breast Cancer (Cell),GSTM2,GSTP1,0.42486155900000,-0.68695521,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTM2,PIK3CA,0.35917783000000,-0.257072823,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTM2,RALBP1,0.04468104200000,1.096416898,Tendency towards co-occurrence(Significant)
Breast Cancer (Cell),GSTP1,PIK3CA,0.44812396400000,-0.073117589,Tendency towards mutual exclusivity
Breast Cancer (Cell),GSTP1,RALBP1,0.53861005800000,-0.093193777,Tendency towards mutual exclusivity
Breast Cancer (Cell),PIK3CA,RALBP1,0.18562833400000,-0.272039295,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,TP53,0.00001190000000,1.084830149,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),MYC,GSTA1,0.26252277200000,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,GSTM2,0.45411840200000,-0.292478245,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,GSTP1,0.21991072100000,-0.549388659,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,PIK3CA,0.38147987900000,-0.106965992,Tendency towards mutual exclusivity
Breast Cancer (Nature),MYC,RALBP1,0.10134938200000,0.509107731,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTA1,0.30037433200000,0.678548381,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTM2,0.39613525700000,0.208048925,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,GSTP1,0.37457759800000,0.170625517,Tendency towards co-occurrence
Breast Cancer (Nature),TP53,PIK3CA,0.02651283000000,-0.390294766,Tendency towards mutual exclusivity(Significant)
Breast Cancer (Nature),TP53,RALBP1,0.00020851400000,1.090146388,Tendency towards co-occurrence(Significant)
Breast Cancer (Nature),GSTA1,GSTM2,0.70959572900000,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,GSTP1,0.56526368800000,#NAME?,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,PIK3CA,0.11651555300000,-1.544899391,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTA1,RALBP1,0.18573004800000,1.155770703,Tendency towards co-occurrence
Breast Cancer (Nature),GSTM2,GSTP1,0.52391702300000,0.179867568,Tendency towards co-occurrence
Breast Cancer (Nature),GSTM2,PIK3CA,0.32468167500000,-0.308877231,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTM2,RALBP1,0.47157718000000,0.210857864,Tendency towards co-occurrence
Breast Cancer (Nature),GSTP1,PIK3CA,0.22916137400000,-0.330523269,Tendency towards mutual exclusivity
Breast Cancer (Nature),GSTP1,RALBP1,0.06352696900000,-1.579665754,Tendency towards mutual exclusivity
Breast Cancer (Nature),PIK3CA,RALBP1,0.23098056200000,0.257059212,Tendency towards co-occurrence
LGG+GBM,MYC,TP53,0.00001770000000,2.042034365,Tendency towards co-occurrence(Significant)
LGG+GBM,MYC,GSTA1,0.19400648900000,1.711314104,Tendency towards co-occurrence
LGG+GBM,MYC,GSTM2,0.88425656800000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,MYC,GSTP1,0.85739307700000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,MYC,PIK3CA,0.64394919300000,-0.063469574,Tendency towards mutual exclusivity
LGG+GBM,MYC,RALBP1,0.91192561300000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,TP53,GSTA1,0.30236694000000,0.670959266,Tendency towards co-occurrence
LGG+GBM,TP53,GSTM2,0.46324305900000,-0.724695538,Tendency towards mutual exclusivity
LGG+GBM,TP53,GSTP1,0.32884530000000,0.787746881,Tendency towards co-occurrence
LGG+GBM,TP53,PIK3CA,0.03621775800000,-0.512719564,Tendency towards mutual exclusivity(Significant)
LGG+GBM,TP53,RALBP1,0.36165012200000,1.074438752,Tendency towards co-occurrence
LGG+GBM,GSTA1,GSTM2,0.96513406100000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,GSTP1,0.95658224100000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,PIK3CA,0.52276859500000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTA1,RALBP1,0.97375133000000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,GSTP1,0.97500118700000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,PIK3CA,0.69080261200000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTM2,RALBP1,0.98494377700000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTP1,PIK3CA,0.62959225400000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,GSTP1,RALBP1,0.98120348400000,#NAME?,Tendency towards mutual exclusivity
LGG+GBM,PIK3CA,RALBP1,0.75787082700000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,TP53,0.42091083700000,0.28611835,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,GSTA1,0.21986180600000,1.658228077,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,GSTM2,0.63754392400000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,GSTP1,0.74194961100000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),MYC,PIK3CA,0.22953448200000,0.736239324,Tendency towards co-occurrence
Glioblastoma (Cell),MYC,RALBP1,0.82014528100000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),TP53,GSTA1,0.08527639500000,1.62924054,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,GSTM2,0.35300272300000,0.512362903,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,GSTP1,0.14233859500000,1.219240276,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,PIK3CA,0.43442457000000,0.144794324,Tendency towards co-occurrence
Glioblastoma (Cell),TP53,RALBP1,0.04096927400000,2.326902401,Tendency towards co-occurrence(Significant)
Glioblastoma (Cell),GSTA1,GSTM2,0.14631186700000,2.161885211,Tendency towards co-occurrence
Glioblastoma (Cell),GSTA1,GSTP1,0.90041319300000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTA1,PIK3CA,0.52441090000000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTA1,RALBP1,0.06731637600000,3.160540248,Tendency towards co-occurrence
Glioblastoma (Cell),GSTM2,GSTP1,0.17317617800000,1.935138052,Tendency towards co-occurrence
Glioblastoma (Cell),GSTM2,PIK3CA,0.31018500500000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTM2,RALBP1,0.88132551900000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),GSTP1,PIK3CA,0.53976525900000,0.389654502,Tendency towards co-occurrence
Glioblastoma (Cell),GSTP1,RALBP1,0.91963909700000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Cell),PIK3CA,RALBP1,0.59724574700000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),MYC,TP53,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTA1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTM2,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,GSTP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,PIK3CA,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),MYC,RALBP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTA1,0.35164835200000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTM2,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,GSTP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,PIK3CA,0.58249139500000,0.110862593,Tendency towards co-occurrence
Glioblastoma (Nature),TP53,RALBP1,0.35164835200000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,GSTM2,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,GSTP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTA1,PIK3CA,0.91208791200000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),GSTA1,RALBP1,0.98901098900000,#NAME?,Tendency towards mutual exclusivity
Glioblastoma (Nature),GSTM2,GSTP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTM2,PIK3CA,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTM2,RALBP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTP1,PIK3CA,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),GSTP1,RALBP1,1.00000000000000,Infinity,Tendency towards co-occurrence
Glioblastoma (Nature),PIK3CA,RALBP1,0.08791208800000,Infinity,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,TP53,0.31255611500000,0.221394897,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,GSTA1,0.42131819400000,-0.353863979,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,MYC,GSTM2,0.13347442400000,1.928815716,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,GSTP1,0.24538433500000,0.549359288,Tendency towards co-occurrence
Stomach +Esophageal Cancer,MYC,PIK3CA,0.15459509100000,-0.618423634,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,MYC,RALBP1,0.24538433500000,0.549359288,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TP53,GSTA1,0.02539265700000,1.898262189,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,TP53,GSTM2,0.37277194800000,Infinity,Tendency towards co-occurrence
Stomach +Esophageal Cancer,TP53,GSTP1,0.41219578800000,-0.271243346,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,TP53,PIK3CA,0.33365421900000,-0.24323031,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,TP53,RALBP1,0.15840537400000,0.966684746,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTA1,GSTM2,0.81898923200000,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,GSTP1,0.35960570000000,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,PIK3CA,0.33015186900000,-0.898458256,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTA1,RALBP1,0.64039430000000,0.043675064,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTM2,GSTP1,0.00870839800000,3.64565072,Tendency towards co-occurrence(Significant)
Stomach +Esophageal Cancer,GSTM2,PIK3CA,0.66125618800000,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,GSTM2,RALBP1,0.16095454900000,2.181224236,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTP1,PIK3CA,0.29921540300000,0.568790164,Tendency towards co-occurrence
Stomach +Esophageal Cancer,GSTP1,RALBP1,0.40708228500000,#NAME?,Tendency towards mutual exclusivity
Stomach +Esophageal Cancer,PIK3CA,RALBP1,0.59802332400000,0.046956983,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,TP53,0.10803170600000,0.423814247,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,GSTA1,0.01890900900000,#NAME?,Tendency towards mutual exclusivity(Significant)
Stomach Adenocarcinoma,MYC,GSTM2,0.38156426300000,1.319283651,Tendency towards co-occurrence
Stomach Adenocarcinoma,MYC,GSTP1,0.47662137400000,-0.215547204,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,MYC,PIK3CA,0.13457170200000,-0.442394077,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,MYC,RALBP1,0.36602674900000,0.238625915,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTA1,0.33751350700000,0.350569386,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTM2,0.23002443200000,Infinity,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,GSTP1,0.19510314000000,0.486508316,Tendency towards co-occurrence
Stomach Adenocarcinoma,TP53,PIK3CA,0.00089800100000,-0.9027137,Tendency towards mutual exclusivity(Significant)
Stomach Adenocarcinoma,TP53,RALBP1,0.33568952900000,0.231457802,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,GSTM2,0.87958857400000,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTA1,GSTP1,0.40463909900000,0.461034959,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,PIK3CA,0.57573307000000,0.031441526,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTA1,RALBP1,0.61559847700000,0.009478744,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTM2,GSTP1,0.16357494000000,2.415063076,Tendency towards co-occurrence
Stomach Adenocarcinoma,GSTM2,PIK3CA,0.48052966500000,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTM2,RALBP1,0.76689892300000,#NAME?,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTP1,PIK3CA,0.28129547500000,-0.44024419,Tendency towards mutual exclusivity
Stomach Adenocarcinoma,GSTP1,RALBP1,0.28344053200000,0.501256173,Tendency towards co-occurrence
Stomach Adenocarcinoma,PIK3CA,RALBP1,0.30278680600000,-0.317867049,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,TP53,0.02996137800000,0.804433356,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,MYC,GSTA1,0.53157079200000,0.101303715,Tendency towards co-occurrence
Head and Neck Cancer,MYC,GSTM2,0.17189921200000,-0.914298699,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,GSTP1,0.35504073400000,0.209720531,Tendency towards co-occurrence
Head and Neck Cancer,MYC,PIK3CA,0.27293430500000,-0.216793466,Tendency towards mutual exclusivity
Head and Neck Cancer,MYC,RALBP1,0.28287573500000,0.347830919,Tendency towards co-occurrence
Head and Neck Cancer,TP53,GSTA1,0.56087135100000,-0.057013539,Tendency towards mutual exclusivity
Head and Neck Cancer,TP53,GSTM2,0.34120832000000,0.470003629,Tendency towards co-occurrence
Head and Neck Cancer,TP53,GSTP1,0.08448808000000,0.707094408,Tendency towards co-occurrence
Head and Neck Cancer,TP53,PIK3CA,0.26876700300000,0.217465844,Tendency towards co-occurrence
Head and Neck Cancer,TP53,RALBP1,0.17822873900000,-0.490622916,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTA1,GSTM2,0.09892815100000,1.192297773,Tendency towards co-occurrence
Head and Neck Cancer,GSTA1,GSTP1,0.21698546100000,-1.144717108,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTA1,PIK3CA,0.04073545800000,1.102282018,Tendency towards co-occurrence(Significant)
Head and Neck Cancer,GSTA1,RALBP1,0.08606274900000,1.07052932,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,GSTP1,0.05923350000000,0.991901334,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,PIK3CA,0.43531406000000,0.195221091,Tendency towards co-occurrence
Head and Neck Cancer,GSTM2,RALBP1,0.11533967700000,#NAME?,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTP1,PIK3CA,0.25496951500000,-0.270173208,Tendency towards mutual exclusivity
Head and Neck Cancer,GSTP1,RALBP1,0.29640958800000,0.375265368,Tendency towards co-occurrence
Head and Neck Cancer,PIK3CA,RALBP1,0.12011313500000,-0.540899801,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,TP53,0.17554735600000,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,GSTA1,0.58634603300000,0.191350964,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,MYC,GSTM2,0.38951500800000,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,GSTP1,0.38951500800000,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,MYC,PIK3CA,0.53443066000000,0.162001554,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,MYC,RALBP1,0.41271892100000,-0.720947069,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTA1,0.69384121500000,-0.116189918,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTM2,0.66524885800000,-0.188052232,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,TP53,GSTP1,0.33475114200000,0.613324907,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,TP53,PIK3CA,0.06706334000000,0.993370474,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,TP53,RALBP1,0.52952954100000,-0.266307213,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTA1,GSTM2,0.47100910400000,0.544536681,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTA1,GSTP1,0.47100910400000,0.544536681,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTA1,PIK3CA,0.28383306100000,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTA1,RALBP1,0.62017162900000,-0.294923234,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTM2,GSTP1,0.02261844500000,1.863116408,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,GSTM2,PIK3CA,0.26049400300000,#NAME?,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTM2,RALBP1,0.15289684700000,0.943220144,Tendency towards co-occurrence
Kidney Clear Cell Carcinoma,GSTP1,PIK3CA,0.63391893300000,-0.262808808,Tendency towards mutual exclusivity
Kidney Clear Cell Carcinoma,GSTP1,RALBP1,0.04063700100000,1.346629105,Tendency towards co-occurrence(Significant)
Kidney Clear Cell Carcinoma,PIK3CA,RALBP1,0.27614430400000,0.491378489,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,TP53,0.55476175900000,0.287682072,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,GSTA1,0.85096153800000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,MYC,GSTM2,0.07692307700000,Infinity,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,GSTP1,0.14903846200000,2.691243083,Tendency towards co-occurrence
Kidney Chromophobe Cancer,MYC,PIK3CA,0.92307692300000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,MYC,RALBP1,0.14903846200000,2.691243083,Tendency towards co-occurrence
Kidney Chromophobe Cancer,TP53,GSTA1,0.43413461500000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,GSTM2,0.66153846200000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,GSTP1,0.43413461500000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,PIK3CA,0.66153846200000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,TP53,RALBP1,0.43413461500000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,GSTM2,0.96923076900000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,GSTP1,0.93894230800000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,PIK3CA,0.96923076900000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTA1,RALBP1,0.93894230800000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,GSTP1,0.96923076900000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,PIK3CA,0.98461538500000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTM2,RALBP1,0.03076923100000,Infinity,Tendency towards co-occurrence(Significant)
Kidney Chromophobe Cancer,GSTP1,PIK3CA,0.96923076900000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,GSTP1,RALBP1,0.93894230800000,#NAME?,Tendency towards mutual exclusivity
Kidney Chromophobe Cancer,PIK3CA,RALBP1,0.96923076900000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,MYC,TP53,0.28138568800000,0.342258174,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTA1,0.59185928200000,0.21190046,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTM2,0.42658877000000,0.78647912,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,GSTP1,0.42658877000000,0.78647912,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,PIK3CA,0.40961786900000,0.340759489,Tendency towards co-occurrence
Lung Adenocarcinoma,MYC,RALBP1,0.71738630800000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,GSTA1,0.02057465100000,2.144761008,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,TP53,GSTM2,0.56557841400000,-0.271933715,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,GSTP1,0.56557841400000,-0.271933715,Tendency towards mutual exclusivity
Lung Adenocarcinoma,TP53,PIK3CA,0.15400000000000,0.560628446,Tendency towards co-occurrence
Lung Adenocarcinoma,TP53,RALBP1,0.55231780800000,-0.560795729,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,GSTM2,0.83644247000000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,GSTP1,0.83644247000000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTA1,PIK3CA,0.03118229900000,1.857941376,Tendency towards co-occurrence(Significant)
Lung Adenocarcinoma,GSTA1,RALBP1,0.89881386600000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTM2,GSTP1,0.89505183200000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTM2,PIK3CA,0.39792240300000,0.887303195,Tendency towards co-occurrence
Lung Adenocarcinoma,GSTM2,RALBP1,0.93591678100000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTP1,PIK3CA,0.60207759700000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,GSTP1,RALBP1,0.93591678100000,#NAME?,Tendency towards mutual exclusivity
Lung Adenocarcinoma,PIK3CA,RALBP1,0.26141117000000,1.590206551,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,TP53,0.29371338000000,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,GSTA1,0.33831625000000,-0.893168314,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,MYC,GSTM2,0.29402261000000,0.596154915,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,GSTP1,0.48402723200000,0.301475395,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,MYC,PIK3CA,0.26383198000000,-0.423814247,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,MYC,RALBP1,0.51597276800000,-0.532654594,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,GSTA1,0.28956844300000,-0.797772132,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,GSTM2,0.35646117900000,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,TP53,GSTP1,0.43102550200000,Infinity,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,TP53,PIK3CA,0.61165385500000,-0.072657646,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,TP53,RALBP1,0.56897449800000,-0.281251182,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTA1,GSTM2,0.56628452400000,0.121696935,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTA1,GSTP1,0.04674211300000,1.379605373,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,GSTA1,PIK3CA,0.09363780400000,0.980829253,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTA1,RALBP1,0.54472754400000,-0.471714494,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTM2,GSTP1,0.39572276600000,0.504136636,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTM2,PIK3CA,0.01109609100000,2.116482813,Tendency towards co-occurrence(Significant)
Lung Squamous Cell Carcinoma,GSTM2,RALBP1,0.60427723400000,-0.340325806,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,GSTP1,PIK3CA,0.12407419200000,1.08026315,Tendency towards co-occurrence
Lung Squamous Cell Carcinoma,GSTP1,RALBP1,0.30333174800000,#NAME?,Tendency towards mutual exclusivity
Lung Squamous Cell Carcinoma,PIK3CA,RALBP1,0.30285750500000,0.560044696,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,TP53,0.04919483500000,1.758550798,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,MYC,GSTA1,0.26403522600000,0.45687063,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,GSTM2,0.16021464700000,0.541597282,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,GSTP1,0.41877829300000,-0.166148698,Tendency towards mutual exclusivity
Ovarian Serous Cancer,MYC,PIK3CA,0.15145766100000,0.278359629,Tendency towards co-occurrence
Ovarian Serous Cancer,MYC,RALBP1,0.16731117200000,-0.463837114,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTA1,0.11794510800000,-1.421385681,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTM2,0.58603888400000,-0.203029187,Tendency towards mutual exclusivity
Ovarian Serous Cancer,TP53,GSTP1,0.25961836900000,Infinity,Tendency towards co-occurrence
Ovarian Serous Cancer,TP53,PIK3CA,0.01827752500000,2.038823204,Tendency towards co-occurrence(Significant)
Ovarian Serous Cancer,TP53,RALBP1,0.59380606100000,0.358531955,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,GSTM2,0.30783008800000,0.693147181,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,GSTP1,0.48578507700000,-0.582799123,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTA1,PIK3CA,0.46852973600000,0.16805911,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTA1,RALBP1,0.43562513000000,-0.683668437,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTM2,GSTP1,0.40943101800000,0.328925031,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTM2,PIK3CA,0.10991492900000,0.639079959,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTM2,RALBP1,0.46946891400000,0.222186155,Tendency towards co-occurrence
Ovarian Serous Cancer,GSTP1,PIK3CA,0.26901760000000,-0.31411533,Tendency towards mutual exclusivity
Ovarian Serous Cancer,GSTP1,RALBP1,0.15577496800000,0.62811471,Tendency towards co-occurrence
Ovarian Serous Cancer,PIK3CA,RALBP1,0.07989729300000,-0.609235208,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,MYC,TP53,0.01352910600000,0.996156589,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,MYC,GSTA1,0.53885468900000,0.389960922,Tendency towards co-occurrence
Prostate Adenocarcinoma,MYC,GSTM2,0.30757086300000,-0.937162306,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,MYC,GSTP1,0.21073168300000,0.565166218,Tendency towards co-occurrence
Prostate Adenocarcinoma,MYC,PIK3CA,0.00136591600000,1.683545885,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,MYC,RALBP1,0.00111836300000,2.133121691,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,TP53,GSTA1,0.39836126600000,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,GSTM2,0.22030457600000,-1.128026174,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,GSTP1,0.08044065300000,-1.526056303,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,PIK3CA,0.40803076400000,-0.47070563,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,TP53,RALBP1,0.47531643300000,-0.609765572,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTA1,GSTM2,0.04038497900000,2.210211773,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTA1,GSTP1,0.00046630000000,3.274680666,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTA1,PIK3CA,0.32558028700000,1.121677562,Tendency towards co-occurrence
Prostate Adenocarcinoma,GSTA1,RALBP1,0.80098644400000,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTM2,GSTP1,0.01262098700000,1.556091932,Tendency towards co-occurrence(Significant)
Prostate Adenocarcinoma,GSTM2,PIK3CA,0.65958604700000,-0.202524264,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTM2,RALBP1,0.48807841500000,#NAME?,Tendency towards mutual exclusivity
Prostate Adenocarcinoma,GSTP1,PIK3CA,0.07862735700000,1.084013489,Tendency towards co-occurrence
Prostate Adenocarcinoma,GSTP1,RALBP1,0.64392319100000,0.030983546,Tendency towards co-occurrence
Prostate Adenocarcinoma,PIK3CA,RALBP1,0.17063120700000,1.156550126,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,TP53,0.61444400800000,0.108213585,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,GSTA1,0.57333201200000,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,MYC,GSTM2,0.68177566800000,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,MYC,GSTP1,0.42666798800000,0.693147181,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,PIK3CA,0.19648883000000,1.033015006,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,MYC,RALBP1,0.50285199900000,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,TP53,GSTA1,0.16391316600000,1.171637424,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TP53,GSTM2,0.41198954400000,0.756569007,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,TP53,GSTP1,0.00398526100000,2.176433808,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,TP53,PIK3CA,0.30181770100000,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,TP53,RALBP1,0.61444400800000,0.108213585,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,GSTM2,0.26653758200000,1.341013657,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,GSTP1,0.06566067700000,1.794510503,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTA1,PIK3CA,0.49700063200000,#NAME?,Tendency towards mutual exclusivity
Papillary Thyroid Carcinoma,GSTA1,RALBP1,0.42666798800000,0.693147181,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTM2,GSTP1,0.00220957800000,2.91506437,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTM2,PIK3CA,0.07314304000000,1.745743232,Tendency towards co-occurrence
Papillary Thyroid Carcinoma,GSTM2,RALBP1,0.00000699000000,3.733331217,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTP1,PIK3CA,0.02411244100000,1.843346838,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,GSTP1,RALBP1,0.01282427200000,2.12272205,Tendency towards co-occurrence(Significant)
Papillary Thyroid Carcinoma,PIK3CA,RALBP1,0.04269517000000,1.572567377,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,MYC,TP53,0.00000358000000,1.732336049,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,MYC,GSTA1,0.52988690400000,0.131691466,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,GSTM2,0.51460405300000,-0.302761179,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,MYC,GSTP1,0.18701842900000,0.583817281,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,PIK3CA,0.09996594800000,0.560543002,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,MYC,RALBP1,0.00401202900000,1.424459769,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,TP53,GSTA1,0.24763603100000,0.47957308,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,GSTM2,0.08103459300000,0.864997437,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,GSTP1,0.00006180000000,1.770319138,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,TP53,PIK3CA,0.14409737200000,0.354518775,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,TP53,RALBP1,0.00000117000000,2.335374916,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,GSTA1,GSTM2,0.28351629600000,#NAME?,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTA1,GSTP1,0.27183235300000,0.631202695,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTA1,PIK3CA,0.57317213200000,-0.029447201,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTA1,RALBP1,0.00293177600000,1.848917883,Tendency towards co-occurrence(Significant)
Uterine Corpus Endometrial Cancer,GSTM2,GSTP1,0.07815217200000,1.129864832,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTM2,PIK3CA,0.14734030200000,0.762140052,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,GSTM2,RALBP1,0.51347590600000,-0.531234495,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTP1,PIK3CA,0.43248954700000,-0.160278901,Tendency towards mutual exclusivity
Uterine Corpus Endometrial Cancer,GSTP1,RALBP1,0.22343853400000,0.633774907,Tendency towards co-occurrence
Uterine Corpus Endometrial Cancer,PIK3CA,RALBP1,0.01281938500000,1.278830795,Tendency towards co-occurrence(Significant)